1. Home
  2. MREO vs MNTK Comparison

MREO vs MNTK Comparison

Compare MREO & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • MNTK
  • Stock Information
  • Founded
  • MREO 2015
  • MNTK 1980
  • Country
  • MREO United Kingdom
  • MNTK United States
  • Employees
  • MREO N/A
  • MNTK N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • MNTK Natural Gas Distribution
  • Sector
  • MREO Health Care
  • MNTK Utilities
  • Exchange
  • MREO Nasdaq
  • MNTK Nasdaq
  • Market Cap
  • MREO 311.8M
  • MNTK 288.8M
  • IPO Year
  • MREO N/A
  • MNTK 2021
  • Fundamental
  • Price
  • MREO $1.84
  • MNTK $2.05
  • Analyst Decision
  • MREO Strong Buy
  • MNTK Hold
  • Analyst Count
  • MREO 5
  • MNTK 3
  • Target Price
  • MREO $7.40
  • MNTK $3.33
  • AVG Volume (30 Days)
  • MREO 1.6M
  • MNTK 147.4K
  • Earning Date
  • MREO 11-10-2025
  • MNTK 11-05-2025
  • Dividend Yield
  • MREO N/A
  • MNTK N/A
  • EPS Growth
  • MREO N/A
  • MNTK N/A
  • EPS
  • MREO N/A
  • MNTK N/A
  • Revenue
  • MREO $500,000.00
  • MNTK $160,682,000.00
  • Revenue This Year
  • MREO N/A
  • MNTK $2.89
  • Revenue Next Year
  • MREO $72.16
  • MNTK $19.36
  • P/E Ratio
  • MREO N/A
  • MNTK N/A
  • Revenue Growth
  • MREO N/A
  • MNTK N/A
  • 52 Week Low
  • MREO $1.47
  • MNTK $1.60
  • 52 Week High
  • MREO $4.29
  • MNTK $5.78
  • Technical
  • Relative Strength Index (RSI)
  • MREO 45.03
  • MNTK 50.93
  • Support Level
  • MREO $1.65
  • MNTK $1.60
  • Resistance Level
  • MREO $1.93
  • MNTK $1.98
  • Average True Range (ATR)
  • MREO 0.12
  • MNTK 0.16
  • MACD
  • MREO -0.02
  • MNTK -0.01
  • Stochastic Oscillator
  • MREO 36.00
  • MNTK 58.41

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

Share on Social Networks: